Marie H. Pahus

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.

Jesper Damsgaard Gunst, Marie H. Pahus, Lena Hagelskjær Kristensen et al. · EClinicalMedicine · 2021 · 192 citations · Full text

Controlled Trial, Covid-19 Pandemic, Clinical Trials +6

SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses

Line K. Vibholm, Stine Sofie Frank Nielsen, Marie H. Pahus et al. · EBioMedicine · 2021 · 166 citations · Full text

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

Jesper Damsgaard Gunst, Marie H. Pahus, Míriam Rosás-Umbert et al. · Nature Medicine · 2022 · 121 citations · Full text

Hiv/aids Counselling, Treatment And Prevention, Human Retrovirus +9

SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity

Stine Sofie Frank Nielsen, Line K. Vibholm, Ida Monrad et al. · EBioMedicine · 2021 · 84 citations · Full text

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

Míriam Rosás-Umbert, Jesper Damsgaard Gunst, Marie H. Pahus et al. · Nature Communications · 2022 · 84 citations · Full text